The Globe and Mail reports in its Tuesday, Dec. 10, edition that ATB Capital Markets analyst Frederico Gomes has downgraded his recommendation for Cresco Labs to "sector perform" from "outperform." The Globe's David Leeder writes in the Eye On Equities column that Mr. Gomes shaved his share target by 75 cents to $3.50. Analysts on average target the shares at $3.60. Mr. Gomes says in a note: "Cresco remains a leading wholesaler of branded products in Illinois, Pennsylvania and Massachusetts, and achieved a No. 3 position in Ohio. However, due to market headwinds on wholesale in key states and limited opportunities for retail growth within the current state footprint, we believe future growth could be limited, which in turn might lead to lower adjusted EBITDA margins due to expense deleveraging on lower sales. While the valuation remains somewhat attractive, the unexciting base-case 2025 outlook with potential lower sales and margins drives our 'sector perform rating." The Globe reported on Aug. 28, 2023, that Echelon analyst Andrew Semple was sticking with his "hold" call on Cresco Labs. The shares could then be had for $1.41.